Deepak Nath's guest appearances

Deepak Nath

Shaping The Future Of Healthcare

The MM+M Podcast

Guy Kawasaki

Ethan Lindenberger

John Glaser

Rachel Berman

Eli Lilly

Johns Hopkins

Steve Madden

Bill Rancic

Mike Myers

Eugene Lee

Osama Hashmi

Tom Harrison

Joe Miles

Steph Garcia

Kathleen Starr

OwlTail

Angela Rasmussen

It’s just over one year since COVID-19 became a familiar term around the world. Due to quick action and collaborative innovation from science and medicine, vaccines have been developed and are being distributed at a pace unrivaled in human history. But, the work doesn’t stop there.Regularly monitoring vaccine efficacy and surveying human behavior among the vaccinated population are crucial to understanding its durability. Antibody testing will continue to be important, long after vaccines have been administered.Our guest today is Dr. Angela Rasmussen, a virologist and affiliate of the Georgetown Center for Global Health, Science and Security. She collects evidence about the human response to emerging viruses to gain a better understanding of vaccine efficacy. Today we’re discussing all aspects of antibody testing for SARS-CoV-2. We’ll learn how the tests are implemented, how they determine an immune response is present, and why testing for antibodies is such an important part of the battle against this virus. We’ll also hear from University of Missouri (MU) scientists Dr. Mark Daniels, Professor of Immunology, Dr. John R. Middleton, Professor of Livestock Health, and Dr. Enid Schatz, chair of the Department of Public Health. The university is conducting an antibody testing study – both biological and behavioral – and our experts on the ground at MU will walk us through the antibody testing process from start to finish. Some Questions Asked:How can testing help us continue to research and improve vaccine use alongside their distribution? (2:42)What does an ideal testing scenario look like? (4:21)Which behaviors can be more easily changed, and which might be more challenging to shift? (12:13)When do you think people can expect to return to business as usual? (16:19) What You’ll Learn in This Episode:Why it’s hard to determine post-vaccination behavior recommendations (1:30)The importance of following the progress of vaccinated individuals (3:26)How antibody testing works at the University of Missouri (6:56)What we can learn from collecting behavioral data (10:27)Discoveries that were made about antibody levels (13:58)Why it’s important to invest in research now (18:51) Learn more about Dr. Angela Rasmussen:WebsiteTwitter Learn more about Dr. Mark DanielsMU School of MedicineLinkedIn Learn more about Dr. John R. MiddletonMU College of Veterinary Medicine Learn more about Dr. Enid Schatz:MU School of Health ProfessionsLinkedInConnect with President of Laboratory Diagnostics, Deepak Nath:LinkedInTwitter See acast.com/privacy for privacy and opt-out information.

It’s just over one year since COVID-19 became a familiar term around the world. Due to quick action and collaborative innovation from science and medicine, vaccines have been developed and are being distributed at a pace unrivaled in human history. But, the work doesn’t stop there. Regularly monitoring vaccine efficacy and surveying human behavior among the vaccinated population are crucial to understanding its durability. Antibody testing will continue to be important, long after vaccines have been administered. Our guest today is Dr. Angela Rasmussen, a virologist and affiliate of the Georgetown Center for Global Health, Science and Security. She collects evidence about the human response to emerging viruses to gain a better understanding of vaccine efficacy. Today we’re discussing all aspects of antibody testing for SARS-CoV-2. We’ll learn how the tests are implemented, how they determine an immune response is present, and why testing for antibodies is such an important part of the battle against this virus. We’ll also hear from University of Missouri (MU) scientists Dr. Mark Daniels, Professor of Immunology, Dr. John R. Middleton, Professor of Livestock Health, and Dr. Enid Schatz, chair of the Department of Public Health. The university is conducting an antibody testing study – both biological and behavioral – and our experts on the ground at MU will walk us through the antibody testing process from start to finish. Some Questions Asked:How can testing help us continue to research and improve vaccine use alongside their distribution? (2:42)What does an ideal testing scenario look like? (4:21)Which behaviors can be more easily changed, and which might be more challenging to shift? (12:13)When do you think people can expect to return to business as usual? (16:19) What You’ll Learn in This Episode:Why it’s hard to determine post-vaccination behavior recommendations (1:30)The importance of following the progress of vaccinated individuals (3:26)How antibody testing works at the University of Missouri (6:56)What we can learn from collecting behavioral data (10:27)Discoveries that were made about antibody levels (13:58)Why it’s important to invest in research now (18:51) <h4>Learn more about Dr. Angela Rasmussen:</h4> <a href="https://angelarasmussen.org/" rel="noopener noreferrer nofollow" target="_blank">Website</a><a href="https://twitter.com/angie_rasmussen?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor" rel="noopener noreferrer nofollow" target="_blank">Twitter</a> <h4>Learn more about Dr. Mark Daniels</h4> <a href="https://medicine.missouri.edu/faculty/mark-daniels-phd" rel="noopener noreferrer nofollow" target="_blank">MU School of Medicine</a><a href="https://www.linkedin.com/in/mark-daniels-47382022/" rel="noopener noreferrer nofollow" target="_blank">LinkedIn</a><h3> </h3><h4>Learn more about Dr. John R. Middleton</h4> <a href="https://cvm.missouri.edu/cvm-food-animal-veterinarian-takes-on-advisory-role-with-avma-council-on-research/" rel="noopener noreferrer nofollow" target="_blank">MU College of Veterinary Medicine</a> <h4>Learn more about Dr. Enid Schatz:</h4><h4> </h4><a href="https://healthprofessions.missouri.edu/personnel/enid-j-schatz/" rel="noopener noreferrer nofollow" target="_blank">MU School of Health Professions</a><a href="https://www.linkedin.com/in/enid-schatz-9475124/" rel="noopener noreferrer nofollow" target="_blank">LinkedIn</a> <h4>Connect with <a href="https://www.linkedin.com/company/siemens-healthineers/" rel="noopener noreferrer nofollow" target="_blank">President of Laboratory Diagnostics</a>, Deepak Nath:</h4> <a href="https://www.linkedin.com/in/deepak-nath-65b906/" rel="noopener noreferrer nofollow" target="_blank">LinkedIn</a><a href="https://twitter.com/deepaknathphd?lang=en" rel="noopener noreferrer nofollow" target="_blank">Twitter</a> See <a href="https://acast.com/privacy" rel="noopener noreferrer nofollow" target="_blank">acast.com/privacy</a> for privacy and opt-out information.

Understanding Immunity: How Antibody Testing for SARS-CoV-2 Works and What We Can Learn from it with Dr. Angela Rasmussen and the Mizzou Antibody Testing Team | Deepak Nath

Deepak Nath, PhD, president of lab diagnostics for Siemens Healthineers, talks with Marc Iskowitz, MM&amp;M executive editor, about the approach to promoting SARS-CoV-2 antibody testing amid unknowns about its immunity-determining potential, plus his firm’s future plans for educating an expanded group of stakeholders about such testing.

Marketers@Home Episode 4: Siemens Healthineers' Deepak Nath